Omicron News and Research

RSS
Computational pipeline for the early identification of emerging SARS-CoV-2 variants

Computational pipeline for the early identification of emerging SARS-CoV-2 variants

16 Aug 2022
A non-covalent inhibitor of 3C-like protease effectively inhibits SARS-CoV-2 replication

A non-covalent inhibitor of 3C-like protease effectively inhibits SARS-CoV-2 replication

16 Aug 2022
Scientists explore nanomolar inhibition of SARS-CoV-2 infection via unmodified peptide targeting spike protein pre-hairpin intermediate

Scientists explore nanomolar inhibition of SARS-CoV-2 infection via unmodified peptide targeting spike protein pre-hairpin intermediate

15 Aug 2022
MHRA approves first bivalent COVID-19 booster vaccine

MHRA approves first bivalent COVID-19 booster vaccine

15 Aug 2022
The symptoms and quality of life among individuals with post-acute sequelae of SARS-CoV-2

The symptoms and quality of life among individuals with post-acute sequelae of SARS-CoV-2

15 Aug 2022
The impact of vaccination and prior infection on the infectiousness of individuals with SARS-CoV-2 Omicron infections in prison settings

The impact of vaccination and prior infection on the infectiousness of individuals with SARS-CoV-2 Omicron infections in prison settings

15 Aug 2022
Superior protection with 'mix-and-match' COVID-19 booster strategy

Superior protection with 'mix-and-match' COVID-19 booster strategy

14 Aug 2022
In monkeys, spike-based vaccines produce some immunity based on CD8 T-cells

In monkeys, spike-based vaccines produce some immunity based on CD8 T-cells

14 Aug 2022
How well does hybrid immunity protect against SARS-CoV-2 and its variants?

How well does hybrid immunity protect against SARS-CoV-2 and its variants?

14 Aug 2022
Mechanistic insights into engineered ACE2 receptor traps

Mechanistic insights into engineered ACE2 receptor traps

12 Aug 2022
Bispecific antibody exhibits high breadth and potency against SARS-CoV-2 Omicron sub-lineages

Bispecific antibody exhibits high breadth and potency against SARS-CoV-2 Omicron sub-lineages

12 Aug 2022
Influence of SARS-CoV-2 breakthrough infection and age on humoral immunity post-three-dose COVID-19 vaccination

Influence of SARS-CoV-2 breakthrough infection and age on humoral immunity post-three-dose COVID-19 vaccination

12 Aug 2022
National follow-up study identifies risk factors for a prolonged COVID-19 recovery

National follow-up study identifies risk factors for a prolonged COVID-19 recovery

12 Aug 2022
Experts urge FDA to include T cell responses when evaluating COVID vaccines

Experts urge FDA to include T cell responses when evaluating COVID vaccines

11 Aug 2022
Children hospitalized with COVID-19 commonly experience neurologic complications

Children hospitalized with COVID-19 commonly experience neurologic complications

11 Aug 2022
SARS-CoV-2 receptor-binding domain-based protein subunit vaccine shows promise against multiple SARS-CoV-2 variants

SARS-CoV-2 receptor-binding domain-based protein subunit vaccine shows promise against multiple SARS-CoV-2 variants

11 Aug 2022
Refined analysis method provides new insights into the dominance transition of Omicron sublineages

Refined analysis method provides new insights into the dominance transition of Omicron sublineages

10 Aug 2022
The features of the newly emerging SARS-CoV-2 Omicron BA.2.75 subvariant

The features of the newly emerging SARS-CoV-2 Omicron BA.2.75 subvariant

10 Aug 2022
Scientists present highly accurate novel framework for SARS-CoV-2 genomic surveillance

Scientists present highly accurate novel framework for SARS-CoV-2 genomic surveillance

10 Aug 2022
A direct lineage-typing RT-PCR assay reveals insights into the transition from Omicron BA.1 to BA.2 dominance in Sweden

A direct lineage-typing RT-PCR assay reveals insights into the transition from Omicron BA.1 to BA.2 dominance in Sweden

10 Aug 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback